In this MBA DecisionWire Spotlight, which highlights MBA candidates’ choices as shared in Clear Admit’s DecisionWire, we highlight a few posts in which several future MBAs seem to be leaning to North Carolina’s most prominent business schools—Duke / Fuqua and UNC Kenan-Flager.
Our first candidate, located in Washington DC, gained acceptance to Duke / Fuqua and NYU Stern, but was curious to know more about each school’s social impact career tracks:
The original poster notes that they hope to transition from a background in nonprofits to “CSR” (corporate social responsibility) after they earn their MBA. Clear Admit resident expert, Alex Brown, dug into the poster’s geographic preference, although the map seemed pretty wide:
Fellow Clear Admit admission expert, Graham Richmond, also weighed in, taking careful consideration of the scholarship advantage the original poster has with Duke / Fuqua, as well as important inquiries they made regarding the community and career potential. Another community member also chimed in, agreeing with Richmond’s sentiments:
Just a few days later, another MBA candidate accepted to Duke / Fuqua, as well as Cornell / Johnson, inquired about which school could be better for investment banking and international brand recognition:
A member of the community dutifully notes that while both schools are comparable in terms of brand recognition and strength in investment banking education, the difference may be in “fit/culture,” as well as upstate New York’s jarring winter weather. Alex Brown concurred with those sentiments:
Branding, however, was still the primary focus, but the community seemed fairly confident in both schools:
Yet another undecided candidate potentially looking at enrollment in the state of North Carolina hit up the DecisionWire boards recently, this time considering UNC Kenan-Flager:
With a hopeful career in healthcare consulting, OP seemed undecided about enrolling in UNC Kenan-Flager or Emory / Goizueta, concerned with which Southeast school offered a better potential career in “Pharma/biotech.” Alex Brown assured that both options were very comparable, and that the choice should likely come down to fit:
A thankful OP assured Brown that the fit seemed great at both schools, but the concern still came down to post-graduate employment:
Congrats on your acceptances and best of luck with your decision!
See more feedback on MBA admissions decisions at:
- MBA DecisionWire Spotlight: Brand Influence
- MBA DecisionWire Spotlight: Michigan / Ross or NYU / Stern for Investment Banking
- MBA DecisionWire Spotlight: Chicago Booth, MIT / Sloan or Wharton for Media Goals
Do you know where you’ll be going? Do you have a tough decision before arriving on campus? Share your story on DecisionWire. It’s completely anonymous and only takes a minute to complete.
